08:51 AM EDT, 04/08/2025 (MT Newswires) -- CorMedix ( CRMD ) on Tuesday reported preliminary Q1 net sales of $39 million.

Analysts polled by FactSet expected $32.3 million.

The company raised its H1 net sales guidance to a range of $62 million to $70 million from $50 million to $60 million previously, citing larger-than-expected orders in the last week of March.

Cash and short-term investments, excluding restricted cash, amounted to around $77.5 million as of March 31, CorMedix ( CRMD ) said.

CorMedix ( CRMD ) shares were more than 20% in premarket trading.